I'm LongbridgeAI, I can summarize articles.Akebia Therapeutics granted stock options for 61,000 shares to two new hires on July 31, 2026. The exercise price is $1.32 per share, matching the closing price. The awards vest over four years, with 25% after one year and the remainder in quarterly installments, carrying a 10-year term.
- Akebia granted 2 new hires stock options for 61,000 shares on July 31, 2026. * Exercise price set at $1.32 per share, matching the closing price on the grant date. * Awards vest over four years: 25% after one year, remaining 75% in quarterly installments. * Options carry a 10-year term. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akebia Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608031605PRIMZONEFULLFEED9802672) on August 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)